Market Closed -
Other stock markets
|
|
5-day change | 1st Jan Change | |
82.61 USD | -0.15% | +0.52% | +14.83% |
Financials (USD)
Sales 2023 * | 17.72B | Sales 2024 * | 17.9B | Capitalization | 48.28B |
---|---|---|---|---|---|
Net income 2023 * | 5.03B | Net income 2024 * | 3.64B | EV / Sales 2023 * | 2,97x |
Net Debt 2023 * | 4.38B | Net Debt 2024 * | 3.74B | EV / Sales 2024 * | 2,91x |
P/E ratio 2023 * | 9,88x | P/E ratio 2024 * | 12,8x | Employees | 12,882 |
Yield 2023 * | 2,03% | Yield 2024 * | 2,28% | Free-Float | 38.98% |
More Fundamentals
* Assessed data
More news
More recommendations
More press releases
1 day | -0.15% | ||
1 week | +0.52% | ||
Current month | -0.12% | ||
1 month | +0.46% | ||
3 months | +11.33% | ||
6 months | +23.06% | ||
Current year | +14.83% |
1 week
81.31
83.33

1 month
80.15
83.45

Current year
60.20
83.45

1 year
60.20
83.45

3 years
42.73
83.45

5 years
23.07
83.45

10 years
23.07
83.45

Managers | Title | Age | Since |
---|---|---|---|
Dan Amos
CEO | Chief Executive Officer | 71 | 1972 |
Max Brodén
DFI | Director of Finance/CFO | 44 | 2017 |
President | 60 | 2015 |
Members of the board | Title | Age | Since |
---|---|---|---|
Dan Amos
CEO | Chief Executive Officer | 71 | 1972 |
Barbara Rimer
BRD | Director/Board Member | 74 | 1994 |
William Bowers
BRD | Director/Board Member | 66 | 2012 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
10.54% | 53 M€ | -1.61% | - | |
4.68% | 87 M€ | 0.00% | ||
4.67% | 356 M€ | +9.15% | ||
3.63% | 66 M€ | +18.09% | - |
Date | Price | Change | Volume |
---|---|---|---|
23-12-05 | 82.61 | -0.15% | 3,017,906 |
23-12-04 | 82.73 | +0.15% | 2,217,251 |
23-12-01 | 82.61 | -0.12% | 2,016,215 |
23-11-30 | 82.71 | +1.32% | 6,219,359 |
23-11-29 | 81.63 | -0.67% | 2,158,180 |
Delayed Quote Nyse, December 05, 2023 at 04:00 pm EST
More quotes
Aflac Incorporated is a life insurance group organized around 3 sectors of activity:
- sale of health and life insurance products in Japan (64.5% of net sales): including cancer life plans, general medical indemnity plans, medical/sickness riders, care plans, living benefit life plans, ordinary life insurance plans and annuities;
- sale of health and life insurance products in the United States (34.1%): including accident/disability plans, cancer expense plans, short-term disability plans, sickness and hospital indemnity plans, hospital intensive care plans, fixed-benefit dental plans, vision care plans, and long-term care plans;
- other (1.4%).
Sector
Life & Health Insurance
Calendar
2024-01-30
- Q4 2023 Earnings Release (Projected)
Trading Rating :
Investor Rating :
ESG Refinitiv :
B
Sell
Buy

Mean consensus
HOLD
Number of Analysts
14
Last Close Price
82.61USD
Average target price
79.78USD
Spread / Average Target
-3.43%
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+14.83% | 48 276 M $ | |
+12.34% | 69 030 M $ | |
-11.61% | 47 350 M $ | |
+11.51% | 35 967 M $ | |
-1.43% | 35 423 M $ | |
+13.99% | 30 850 M $ | |
+40.00% | 30 114 M $ | |
+10.80% | 29 985 M $ | |
-24.31% | 29 471 M $ | |
+13.88% | 21 183 M $ |